Alter HJ: The cloning and clinical implications of HGVand HGBV-C. N Engl J Med 334:1536, 1996

Brillanti S et al: A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alpha-resistant chronic hepatitis Gastroenterology 107:812, 1994

Chemello L et al: Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis Hepatology 22:700, 1995

Czaja AJ et al: Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 103:1290, 1992

Czaja AJ: Autoimmune hepatitis: Evolving concepts and treatment strategies. Dig Dis Sci 40:435, 1995

Czaja AJ: The variant forms of antoimmune hepatitis. Ann Intern Med 125:588, 1996

Davis GL et al: Treatment of chronic hepatitis with recombinant interferon alfa: A multicenter randomized, controlled trial. N Engl J Med 321: 1501, 1989

Desmet VJ et al: Classification of chronic hepatitis: Diagnosis, grading, and staging. Hepatology 19:1513, 1994

Dienstag JL et al: A preliminary trial of lamivudine for chronic hepatitis infection. N Engl J Med 333:1657, 1995

Enomoto N et al: Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis virus lb infection. N Engl J Med 334:77, 1996

Farci P et al: Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med 330:88, 1994

Garson JA et al: Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis J Med Virol 45:348, 1995

Hoofnagle JH, DiBisceglie AM: The treatment of chronic viral hepatitis. N Engl J Med 336:347, 1997

Hoofnagle JH, Jones EA (guest eds.): Interferon therapy of chronic viral hepatitis. Semin Liver Dis 9:231, 1989

Hoofnagle JH: Therapy of acute and chronic viral hepatitis. Adv Intern Med 39:241, 1994

Ishak et al: Histologic grading and staging of chronic hepatitis. J Hepatol 22:696, 1995

Johnson PJ et al: Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 333:958, 1995

Kasahara A et al: Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial. Hepatology 21:291, 1995

Katkov WN, Dienstag JL: Prevention and therapy of viral hepatitis. Semin Liver Dis 11:165, 1991

Korenman J et al: Long-term remission of chronic hepatitis after alpha-interferon therapy. Ann Intern Med 114:629, 1991

Krawitt EL: Autoimmune hepatitis. N Engl J Med 334:897, 1996

Maddrey WC: Chronic hepatitis. Dis Mon 39:53, 1993

Masuko et al: Infection with hepatitis GB virus in patients on maintenance dialysis. N Engl J Med 334:1485, 1996

Niederau et al: Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 334:1422, 1996

Perrillo RP et al: A randomized, controlled trial of interferon alpha-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 323:295, 1990

Poynard T et al: A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 332:1457, 1995

Reichard et al: High sustained response rate and clearance of viremia in chronic hepatitis after treatment with interferon-alfa-2b for 60 weeks. Hepatology 19:280, 1994

Reichard et al: Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis responding in a sustained fashion to interferon alfa-2b treatment. Hepatology 21:918, 1995

Romeo R et al: Eradication of hepatitis virus RNA after alpha-interferon therapy. Ann Intern Med 121:276, 1994

Shindo M et al: Hepatic hepatitis virus RNA as a predictor of a long-term response to interferon-alfa therapy. Ann Intern Med 122:586, 1995

Tong MJ et al: Clinical outcomes after transfusion-associated hepatitis N Engl J Med 332:1463, 1995